Cyclobenzaprine hydrochloride sustained-release capsules
A technology of cyclobenzaprine hydrochloride and sustained-release capsules, which is applied in the field of medicine, can solve problems such as unsuitability for industrial production and complicated production process, and achieve the effects of maintaining blood drug concentration, stabilizing blood drug concentration, and good patient compliance
Active Publication Date: 2015-04-22
CP PHARMA QINGDAO CO LTD
View PDF5 Cites 7 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
CN103068375A relates to a tablet sleeve of cyclobenzaprine. CN102065691A mainly involves multiple coatings to form drug-containing sustained-release beads. The production process is complex and not suitable for industrial production
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1-4
[0013] The preparation of embodiment 1-4 cyclobenzaprine hydrochloride sustained-release capsules
[0014] According to the raw and auxiliary materials in the following table, the cyclobenzaprine hydrochloride sustained-release capsules of four examples were prepared according to the above-mentioned preparation method. Among them, " / " means not used.
[0015] Table 1 Examples 1-4
[0016]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention provides a method for preparing cyclobenzaprine hydrochloride sustained-release capsules and belongs to the technical field of medicines. The cyclobenzaprine hydrochloride sustained-release capsules disclosed by the invention consist of cyclobenzaprine hydrochloride, a sustained-release material, a diluent, an adhesive, a disintegrating agent and a lubricating agent, wherein the main component cyclobenzaprine hydrochloride has the effects of relieving muscle spasm and accompanying severe pain in skeletal muscles, and the sustained-release preparation can stably achieve the effects of relieving pain and spasm. The cyclobenzaprine hydrochloride sustained-release capsules are safe, effective, stable in quality, low in cost and low in administration frequency, and the patient compliance is enhanced.
Description
technical field [0001] The invention belongs to the technical field of medicine, and relates to a preparation method of cyclobenzaprine hydrochloride sustained-release capsules. The invention provides a safe and effective capsule with stable quality, low cost, less frequency of administration, enhanced patient compliance, and stable pain relief. Antispasmodic sustained-release formulation. Background technique [0002] Cyclobenzaprine hydrochloride, whose chemical name is 5-(3-dimethylaminopropene) dibenzo[a,e] cycloheptatriene hydrochloride, is a muscle relaxant developed by Merck in the United States. Muscle spasm and its accompanying severe pain in skeletal muscles have been clinically used for many years and are safe and effective. CN103068375A relates to a tablet sleeve for cyclobenzaprine. CN102065691A mainly involves multiple coatings to form drug-containing sustained-release beads. The production process is complicated and is not suitable for industrial production. ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K9/52A61K31/135A61K47/38A61K47/36A61P21/02
Inventor 王明刚任莉陈阳生孙桂玉翟翠云刘晓霞
Owner CP PHARMA QINGDAO CO LTD
Features
- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
Why Patsnap Eureka
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com